Lumida
/CTMX
⌘K
CytomX Therapeutics Inc

CytomX Therapeutics Inc

CTMX
$3.29USD-1.79%-0.06 today

MARKET CAP

716.9M

P/E (TTM)

FWD P/E

DAY RANGE

$3 – $3

52W RANGE

$2
$8

AI Summary

Stalk
Buy NowMedium

CTMX is showing early Stage 1 repair after the mid-June low, confirmed by a Bullish Pivot Point pattern and stacked short-term EMAs; medium-term bias shifts bullish, and execution on holds above the EMA9/20 support is warranted.

  • ORR of 28% and median PFS of 7.1 months in colorectal cancer
  • $346.7M cash as of Q1 2026 underpins R&D runway through 2027
  • Q1 2026 revenue dropped 80% to $10.3M from $50.9M YoY
Full analysis →
Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income